David G. Huntsman

Top papers

• Integrated genomic analyses of ovarian carcinoma

  Debra Bell, Andrew Berchuck, Andrew Berchuck, et al.·2011·Nature
  ↗ 8,099OA
• The clonal and mutational evolution spectrum of primary triple-negative breast cancers

  Sohrab P. Shah, Andrew Roth, Rodrigo Goya, et al.·2012·Nature
  ↗ 2,018
• <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas

  Kimberly C. Wiegand, Sohrab P. Shah, Osama M. Al‐Agha, et al.·2010·New England Journal of Medicine
  ↗ 1,683OA
• Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

  David D.L. Bowtell, Steffen Böhm, Ahmed A. Ahmed, et al.·2015·Nature reviews. Cancer
  ↗ 1,412OA
• Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

  Fiona M. Blows, Kristy Driver, Marjanka K. Schmidt, et al.·2010·PLoS Medicine
  ↗ 1,150OA
• Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

  Karen A. Gelmon, Marc Tischkowitz, Helen Mackay, et al.·2011·The Lancet Oncology
  ↗ 1,111
• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

  Sohrab P. Shah, Ryan D. Morin, Jaswinder Khattra, et al.·2009·Nature
  ↗ 1,075OA
• Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer

  Aline Talhouk, Melissa K. McConechy, Samuel Leung, et al.·2017·Cancer
  ↗ 938OA
• A clinically applicable molecular-based classification for endometrial cancers

  Aline Talhouk, Melissa K. McConechy, Samuel Leung, et al.·2015·British Journal of Cancer
  ↗ 934OA
• Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

  Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.·2012·The Lancet Oncology
  ↗ 921OA
• Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

  Cristina E. Tognon, Stevan R. Knezevich, David G. Huntsman, et al.·2002·Cancer Cell
  ↗ 901OA
• Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

  Martin Köbel, Steve E. Kalloger, Niki Boyd, et al.·2008·PLoS Medicine
  ↗ 817OA